Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan A. Dyckerhoff Sells 25,000 Shares

Key Points

• Director Stefan A. Dyckerhoff of Astera Labs sold 25,000 shares at an average price of $173.42, totaling $4.3 million in a significant decrease of their ownership by 20.14%.
• The company reported $0.44 earnings per share for the quarter, beating estimates by $0.11, with revenue increasing by 149.5% year-over-year to $191.93 million.
• Astera Labs stock has been rated a "Moderate Buy" by analysts, with a consensus target price of $129.13 despite mixed ratings from various research firms.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Stefan A. Dyckerhoff sold 25,000 shares of Astera Labs stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $173.42, for a total transaction of $4,335,500.00. Following the transaction, the director directly owned 99,154 shares in the company, valued at approximately $17,195,286.68. This trade represents a 20.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Astera Labs Stock Up 0.1%

Astera Labs stock traded up $0.15 during mid-day trading on Monday, hitting $179.43. 4,765,213 shares of the company were exchanged, compared to its average volume of 6,896,421. The business has a fifty day moving average of $107.68 and a 200 day moving average of $87.31. The company has a market capitalization of $29.82 billion, a PE ratio of 320.41, a price-to-earnings-growth ratio of 7.63 and a beta of 1.39. Astera Labs, Inc. has a 1-year low of $36.85 and a 1-year high of $185.75.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%. The business had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. During the same quarter last year, the business earned $0.13 earnings per share. The firm's quarterly revenue was up 149.5% compared to the same quarter last year. Research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have recently commented on ALAB. Wall Street Zen lowered shares of Astera Labs from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Stifel Nicolaus set a $145.00 price objective on shares of Astera Labs and gave the stock a "buy" rating in a report on Monday, August 4th. Susquehanna upped their price objective on shares of Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a report on Thursday. Northland Capmk downgraded shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 22nd. Finally, Needham & Company LLC upped their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Four research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $129.13.

Hedge Funds Weigh In On Astera Labs

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in Astera Labs by 29.6% in the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company's stock valued at $1,089,491,000 after acquiring an additional 2,751,747 shares during the period. Alliancebernstein L.P. grew its holdings in shares of Astera Labs by 114.2% during the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock worth $501,289,000 after purchasing an additional 4,478,741 shares in the last quarter. Atreides Management LP grew its holdings in shares of Astera Labs by 153.3% during the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock worth $277,601,000 after purchasing an additional 2,815,614 shares in the last quarter. Lord Abbett & CO. LLC boosted its stake in Astera Labs by 318.9% in the fourth quarter. Lord Abbett & CO. LLC now owns 1,818,600 shares of the company's stock valued at $240,873,000 after buying an additional 1,384,498 shares in the last quarter. Finally, Fred Alger Management LLC boosted its stake in Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock valued at $93,087,000 after buying an additional 179,638 shares in the last quarter. Institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.